Predictive Modeling of Drug Treatment in the Area of Personalized Medicine

Area of Science:

• Computational biology
• Oncology
• Pharmacology

Background:

• Cancer treatment success rates remain modest despite advances in understanding disease mechanisms.
• Current statistical methods inadequately capture the complex tumor/patient/drug interactions.
• Mechanistic modeling offers a way to resolve this complexity.

Purpose of the Study:

• To describe how mechanistic virtual patient models can shift the theranostic paradigm in oncology.
• To highlight the potential of these models for personalized medicine and targeted drug development.
• To introduce the ModCell™ platform for individualized treatment response prediction.

Main Methods:

• Generating large-scale in silico models using fundamental knowledge of biological system interactions.
• Systematic molecular characterization of patients and their diseases.
• Developing and applying the ModCell™ mechanistic modeling platform.

Main Results:

• Mechanistic virtual patient models can be generated with predictive capabilities.
• These models have the potential to individualize treatment response predictions.
• The ModCell™ platform demonstrates a viable approach for personalized oncology.

Conclusions:

• Mechanistic modeling is crucial for addressing the complexity of cancer treatment.
• Virtual patient models can revolutionize personalized medicine and drug development in oncology.
• The ModCell™ platform provides a promising tool for predicting patient responses to therapy.